Effect of Short Sprint Interval Training With Active Recovery as Compared to Passive Recovery on Anaerobic Capacity in Non-athletic Population

October 2, 2024 updated by: Foundation University Islamabad
Short Sprint Interval Training (SSIT) is a modified form of Sprint Interval Training (SIT) defined as "small bouts of supramaximal exercise with recovery periods between them to increase peak oxygen uptake in spite of having a less amount of exercise volume". SSIT was developed so that non- athletic population could also perform a training which was originally designed for athletes to increase anaerobic capacity. The benefit of this type of exercise is that it is time efficient and yields the result in short amount of time as compared to other type of exercises due to its vigorous nature. Moreover this sort of training is mostly performed in lab setting rather than on field, therefore the aim of this study is to determine the effect of short sprint interval training in a field with active recovery as compared to passive recovery on anaerobic capacity in non-athletic population.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Based on a global health initiative to promote "Exercise is Medicine" strategy by American College of Sports Medicine, designing an exercise prescription which is time efficient, cost-effective, easily performable and has great adherence or compliance is necessary. SIT is a type of Anaerobic training which not only enhances the anaerobic capacity but also the aerobic capacity of an individual as well. Thus SIT plays a crucial role in prevention of the NCDs by maintain and improving CRF. Classic SIT is limited to athletic population therefore this study aims to promote the use of modified SIT training protocol called as SSIT by shortening the sprinting time from 30s to 10s so that non-athletic individuals are able to perform it. Apparently there are lack of field based studies on SIT. Most studies use lab based training performed on treadmill and cycle ergometer which can be expensive and time-consuming, especially when several subjects have to train at the same time. Furthermore no comparison has been made between active and passive recovery in short term sprint interval training in field (a bout of 10 second of less). This study aims to test the novel effects of Short Sprint Interval Training with two different types of recovery method performed on field rather than lab to enhance anaerobic capacity in a short amount of time.

This study would be a single blinded randomized control trial, conducted over a period of 12 months at football ground at F-11/1 Islamabad. Subjects will be selected via non-probability convenience sampling technique, followed by block randomization into two groups, the intervention group A and intervention group B using sealed envelope method. The sample size as calculated by G*Power software will be 38 non -athletic individuals. Informed consent will be taken from individuals selected as per inclusion criteria. Participants then being allocated to one of the 2 groups, will be required to complete a self-reporting demographic form. For training, participants will perform SSIT 3 times a week for a total duration of 02 weeks. Anaerobic capacity of the participants will be measured using running based anaerobic sprint test (RAST) before intervention and after intervention of two weeks. Collected data will then be entered and analyzed on the SPSS software version 23.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
38

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Pakistan
    • Punjab
      • Rawalpindi, Punjab, Pakistan, 46000
        • Recruiting
        • Foundation University College of Physical Therapy
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male and Female young adults ranging from 18-25 Years of age.
  • Young adults who perform moderate to vigorous Intensity exercise at least once a week according to IPAQ.
  • Those who are cleared for physical activity after screening through PAR-Q.

Exclusion Criteria:

  • Young adults having history of any Musculoskeletal, cardiovascular, pulmonary and neurological Disorder.
  • Young adults having history of injury in the past 30 days.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Interventional group

Participants in this group will perform short sprint interval training on a flat running track in field. Each lane will be materialized by placing cones 5 m from each other for a total of 30 m on which Subject will perform Short Sprint Interval Training.

The instructions will be to travel the greatest distance possible in 10 seconds, making trips of 5, 10, 15 m, etc.

Participants of this group will opt for 1 minute of active recovery i.e. they will perform brisk walk between 6 bouts of 10 sec sprint.

The duration of the training will be of 2 weeks.
Other: Short Sprint Interval Training with Active Recovery

Participants will perform short sprint interval training on a flat running track in field. Each lane will be materialized by placing cones 5 m from each other for a total of 30 m on which the Subjects will perform Short Sprint Interval Training.

The instructions will be to travel the greatest distance possible in 10 seconds, making trips of 5, 10, 15 m, etc.

Participants will opt for 1 minute of active recovery i.e. they will perform brisk walk between 6 bouts of 10 sec sprint.

The duration of the training will be of 2 weeks.
Active Comparator: Control group

Patients will Participants in this group will perform short sprint interval training on a flat running track in field. Each lane will be materialized by placing cones 5 m from each other for a total of 30 m on which Subject will perform Short Sprint Interval Training.

The instructions will be to travel the greatest distance possible in 10 seconds, making trips of 5, 10, 15 m, etc.

Participants of this group will opt for 1 minute of passive recovery i.e. they will stay stationary between 6 bouts of 10 sec sprint.

The duration of the training will be of 2 weeks.
Other: Short Sprint Interval Training with passive recovery

Participants will perform short sprint interval training on a flat running track in field. Each lane will be materialized by placing cones 5 m from each other for a total of 30 m on which Subject will perform Short Sprint Interval Training.

The instructions will be to travel the greatest distance possible in 10 seconds, making trips of 5, 10, 15 m, etc. Participants will opt for 1 minute of active recovery i.e. they will perform brisk walk between 6 bouts of 10 sec sprint.

The duration of the training will be of 2 weeks.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Anaerobic Capacity
Time Frame: 2 weeks
Evaluation will be done using field test known as Running Based Anaerobic Sprint Test (RAST)
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Foundation University Islamabad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 15, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 1, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
October 1, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 2, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 3, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 3, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 2, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
October 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • FUI/CTR/2024/38

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-athletic Active Young Adults

Clinical Trials on Short Sprint Interval Training with Active Recovery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings